GERN Live signals | Maximize Profits with Getagraph.com

SELL 25156 min ago

@ $3.89

Issued: 16 May 2024 @ 14:18

Return: -8.74%

Previous signal: May 16 - 11:02

Previous signal: Buy

Return: 1.83 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies...

Stats
Today's Volume	10.69M
Average Volume	12.77M
Market Cap	2.11B
EPS	$0 ( 2024-05-09 )
Next earnings date	( $-0.110 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.44
ATR14	$0.00700 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-15	Lawlis V Bryan	Buy	35 000	Common Stock
2024-05-15	Lawlis V Bryan	Sell	35 000	Common Stock
2024-05-15	Lawlis V Bryan	Sell	35 000	Stock Option (right to buy)
2024-05-09	Mcdonald John F	Buy	180 000	Stock Option (right to buy)
2024-05-09	Bir Dawn Carter	Buy	180 000	Stock Option (right to buy)

INSIDER POWER
81.90
Last 95 transactions
Buy: 23 282 540 \| Sell: 3 992 187

Volume Correlation

Long: 0.20 (neutral)

Short: -0.02 (neutral)

Signal:(52.493) Neutral

Geron Corp Correlation

10 Most Positive Correlations
CTHR	0.952
BNR	0.947
DXPE	0.944
KNTK	0.934
VTVT	0.93
SWBI	0.926
JAN	0.925
WLDN	0.925
KALU	0.925
WHLR	0.923

10 Most Negative Correlations
LUNA	-0.956
CPSH	-0.955
MTEM	-0.948
AZ	-0.943
ARKO	-0.943
DMRC	-0.942
BSBK	-0.939
TELA	-0.938
CASI	-0.936
NEPH	-0.936

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Geron Corp Correlation - Currency/Commodity

0.00
( neutral )

-0.40
( neutral )

0.00
( neutral )

-0.21
( neutral )

Geron Corp Financials

Annual	2023
Revenue:	$237 000
Gross Profit:	$-795 999 (-335.86 %)
EPS:	$-0.320

FY	2023
Revenue:	$237 000
Gross Profit:	$-795 999 (-335.86 %)
EPS:	$-0.320

FY	2022
Revenue:	$596 000
Gross Profit:	$-272 000 (-45.64 %)
EPS:	$-0.370

FY	2021
Revenue:	$1.39M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.350

Financial Reports:

No articles found.

Geron Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.